Concepedia
Statistics
Publications
12
Citations
1.7K
H-Index
Active since
1999
Affiliations
Beth Israel Deaconess Medical Center(Current)
Harvard University
Infinity Pharmaceuticals (United States)
Syracuse University
Blueprint Medicines (United States)
Margit Hagel is an author at Beth Israel Deaconess Medical Center specializing in life sciences, pharmacology, and oncology.
Publications per year
1999–2024
The Adaptor Protein Paxillin Is Essential for Normal Development in the Mouse and Is a Critical Transducer of Fibronectin Signaling
Margit Hagel, Elizabeth George, Ann Kim et al. · Molecular and Cellular Biology · 2002 · 330 citations · Full text
Life Sciences, Cell Biology, Molecular Biology +17
First Selective Small Molecule Inhibitor of FGFR4 for the Treatment of Hepatocellular Carcinomas with an Activated FGFR4 Signaling Pathway
Margit Hagel, Chandra Miduturu, Michael P. Sheets et al. · Cancer Discovery · 2015 · 315 citations · Full text
Medicine, Oncology, Pharmacology +17
Discovery of a Potent and Orally Active Hedgehog Pathway Antagonist (IPI-926)
Martin Tremblay, André Lescarbeau, Michael J. Grogan et al. · Journal of Medicinal Chemistry · 2009 · 251 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant FGF19 Signaling as a Driver Event in Hepatocellular Carcinoma
Richard D. Kim, Debashis Sarker, Tim Meyer et al. · Cancer Discovery · 2019 · 250 citations · Full text
Characterization of a focal adhesion protein, Hic-5, that shares extensive homology with paxillin
Sheila Μ. Thomas, Margit Hagel, Christopher E. Turner · Journal of Cell Science · 1999 · 157 citations
Life Sciences, Cell Biology, Molecular Biology +13
1–5 of 12